---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-007595"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:26:08.319302+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ra Medical Q1 net loss $66.4M, goodwill impaired $56.1M; revenue $85K

## Summary
- Revenue of $85K vs $9K YoY; net loss $66.4M includes $56.1M goodwill impairment.
- Cash used in operations $12.1M, incl. $5M DOJ settlement payment; cash $12.2M at Mar 31.
- Acquisition of Catheter Precision closed Jan 2023; $8M financing obtained in March.
- CEO Will McGuire resigned; David Jenkins named Interim CEO; Steve Passey appointed CFO.
- VIVO system launch underway with five direct sales reps; LockeT closure device introduced.

## SEC filing metadata
- accession: 0001654954-23-007595
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/0001654954-23-007595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-007595
- JSON: https://secwatch.observer/filing/0001654954-23-007595.json
- Plain text: https://secwatch.observer/filing/0001654954-23-007595.txt

## Key facts
- Earnings Releases
  Catheter Precision, Inc. reported the three months ended March 31, 2023 results: revenue $85 thousand, net income net loss was $66.4 million.
  - Period: the three months ended March 31, 2023
  - Revenue: $85 thousand
  - Net income: net loss was $66.4 million
  - Result: reported results
  source text: Passey. · Announced the resignation of its CEO, and appointment of its new Interim CEO, David Jenkins, as of April 28, 2023. · Revenues for the quarter ended March 31, 2023 were $85 thousand, net loss was $66.4 million and cash used by operations was $12.1 million, which includes a $5.0 million cash payment associated with a legacy settlement. Accounting for the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/0001654954-23-007595-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.